Wilson Therapeutics Company
Wilson Therapeutics focuses on developing novel therapies addressing unmet medical needs in rare diseases.
Technology:
Cancer
Headquarters:
Stockholm, Stockholms Lan, Sweden
Funding Status:
M&A
Founded Date:
2012
Last Funding Type:
Venture - Series Unknown
Investors Number:
2
Estimated Revenue:
$10M to $50M
Employee Number:
11-50
Total Funding:
$27.2M
Industry:
PharmTech
Investor Type:
For Profit